Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “PrimeGene (Beijing) Co., Ltd.”

3 pharma patents match "PrimeGene (Beijing) Co., Ltd." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 3
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 3 pharmaceutical patents matching "PrimeGene (Beijing) Co., Ltd." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

3 results for “PrimeGene (Beijing) Co., Ltd.” · 30,257 patents in full index Clear search

  1. US 12404275

    Pyrazolopyrazine derived compounds, pharmaceutical composition and use thereof

    PrimeGene (Beijing) Co., Ltd. · Granted Sep 2, 2025 · Expires Aug 28, 2045

    granted

  2. US 12304898

    Quinolyl-containing compound and pharmaceutical composition, and use thereof

    PrimeGene (Beijing) Co., Ltd. · Granted May 20, 2025 · Expires May 15, 2045

    granted

  3. US 12129258

    Diaryl macrocyclic compound and pharmaceutical composition, and use thereof

    PrimeGene (Beijing) Co., Ltd. · Granted Oct 29, 2024 · Expires Oct 24, 2044

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.